Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acambis, Inc.
New generation of vaccines to be tested
September 10th, 2003
Two new investigational smallpox vaccines will be studied as part of a clinical trial starting soon at St. Louis University's Center for Vaccine Development. St. Louis University is the only location in the United States participating in the trial. The investigational vaccines, manufactured by Massachusetts-based Acambis, Inc., will be compared with the existing smallpox vaccine, known as Dryvax. The new vaccines were produced using modern methods of cell cultivation. Dryvax, the same smallpox vaccine that was provided to all U.S. residents during the period of routine smallpox vaccination, hasn't been produced in many years. "Although there has not...
Source: Biotech Week (2003-09-10)
|
